Tesla's CEO steals some of rival Rivian's IPO thunder by asking the Twitter universe to decide if he should sell 10% of his Tesla shares.
Google search interest in SPACs has soared in the past week, reaching its highest level since February.
Products ancillary to ownership of the coin itself can come saddled with significant shortcomings.
I suspect that commodity cost inflation may be the biggest factor that's currently weighing on DNUT.
ProQR Therapeutics, Oscar Health and Hims & Hers Health appear to have promising futures.
Here's why I detect a hole in the charts.
The shares of the initial public offering were priced below their initial expected range but the stock is up nicely from its first-day action.
Life has not been easy for the small-cap biotech investor so far in 2021.
Shares in the e-commerce site leapt by the daily limit in Jakarta, with the company paving a path to public markets.
Plus, taking another look at Robinhood post-IPO and what it says about the modern marketplace.